This study was designed to confirm the anti-senescence effects of BK signaling via the B2R pathway in EPCs and to investigate the detailed regulatory mechanism controlling this activity, which has important implications for the treatment of coronary artery disease and diabetes. This evidence concerns the gene BDKRB2 and coronary artery disorder.